How Healthy Are Your Oats?

Not Applicable

Recruiting

• Conditions: Mycotoxin Biomonitoring

• Registration Number: NCT07050680
• Lead Sponsor: University of Aberdeen

Brief Summary

Oat foods are commonly consumed as healthy breakfast options and their nutritional value is well recognised. Oats are a rich source of fibre, micronutrients and non-nutrient bioactive compounds, but at the same time cereals including oats can be contaminated with mycotoxins. To fully understand the nutritional benefits and potential food safety risks of oat consumption, this study aims to assess the nutritional composition of an oat food and the bioavailability of bioactive oat constituents and their metabolite profile in urine of volunteers consuming a single portion of an oat breakfast. This study requires 16 healthy volunteers to consume one portion of oats and collect their urine over 48 hours after the test meal. No other sample collection is required.

Detailed Description

Cereal foods are important part of a healthy, balanced diet. Amongst cereals, oats form an important part of a Scottish diet and are an important agricultural commodity. Oats are well-known for their high nutritional value containing high-quality fatty acids (oleic and linoleic acids), proteins with high amino acid profiles and dietary fibre, most namely in the form of soluble β-glucans. These β-glucans have well-documented health benefits regarding cholesterol-lowering effects in humans. In addition to macronutrients, oats are also a rich source of micronutrients including tocopherols and a range of minerals. As such, the consumption of oats is highly recommended by dietary advice. However, oats and other cereals are also known to be at risk of contamination with naturally occurring fungal toxins called mycotoxins. Previous studies have demonstrated the presence of detectable levels of mycotoxins formed by Fusarium fungi in oat crops and oat foods. Current risk assessments by the European Food Safety Authority and the UK Food Standard Agency aim to establish maximum permitted levels of these mycotoxins in foods. The maximum levels aim to protect consumers from high level exposure and potential health effects.

Rationale for Study This study is part of a wider programme of work investigating the health benefits and potential food safety risks of oats. The presence of phytochemicals and Fusarium mycotoxins in oat foods has been confirmed and the bioaccessibility of these bioactive compounds in the human gut has been demonstrated in-vitro. To fully quantify dietary exposure of individuals to these bioactive compounds, detailed work is needed to understand the rate of bioaccessibility of bioactive compounds from oat foods and their absorption and excretion into urine in humans. This detailed information will inform future studies aimed at assessing dietary exposure and risk.

The proposed study aims to feed a single dose of an oat food to healthy volunteers. The study will assess how the oat food is digested and the bioactive compounds absorbed and excreted in vivo. The food will be selected to contain low and safe mycotoxin levels.

Study Timeline

• Status Verified: 2025-06
• Study Start: 2025-06-02
• Study First Submitted: 2025-06-19
• Study First Submitted QC: 2025-06-30
• Last Update Submitted: 2025-06-30
• Study First Posted: 2025-07-03
• Last Update Posted: 2025-07-03
• Primary Completion: 2027-03
• Study Completion: 2027-03-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Adult males and females (aged 18 - 65 years) who are healthy with a BMI in the normal to overweight range (18.5-29.9)

Exclusion Criteria

• Anyone who currently suffers from gastrointestinal or metabolic diseases, liver disease or kidney disease
• Anyone who currently has an eating disorder (anorexia, bulimia, binge eating, night eating syndrome)
• Anyone who is taking prescribed medication related to gastrointestinal, metabolic, liver or kidney disease
• Anyone who has taken antibiotics in the past 3 months
• Anyone who is allergic or intolerant to oat foods
• Anyone who is currently pregnant or breastfeeding
• Anyone who is currently taking vitamin or mineral supplements (unless they agree to discontinue supplementation 2 weeks before the study)
• Anyone currently participating in another research study
• Anyone who is unable to fluently speak, read and understand English
• Anyone who is unable to give written informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Kinetics of mycotoxin absorption and excretion	Hourly urine sample collection up to 16 hours post-intervention, then bulk urine collection at 24 and 48 hours.	Urinary excretion profile of oat-derived mycotoxins and metabolites will be assessed after consumption of a single oat-based test meal in 16 volunteers. Volunteers will collect hourly urine samples. Samples will be analysed for mycotoxin metabolites using established LC-MS/MS methodology.

Trial Locations

Locations (1)

Rowett Institute, University of Aberdeen; 🇬🇧 Aberdeen, United Kingdom